drugset / Trial / NCT02712554
A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to assess the abuse potential of CL-108 tablets, including the abuse deterrent effects of promethazine, following oral administration, relative to hydrocodone/acetaminophen (APAP) tablets and placebo in non-dependent, recreational opioid users.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CL-108 | Unknown | 22.5 mg | Oral |
| Subject | CL-108 | Unknown | 37.5 mg | Oral |
| Comparator | M366 | Unknown | 22.5 mg | Oral |
| Comparator | M366 | Unknown | 37.5 mg | Oral |
Indications
No indication recorded.